These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31080830)

  • 1. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Sun LC; Chen R; Fu C; Chen Y; Wu Q; Chen R; Lin X; Luo S
    Biomed Res Int; 2019; 2019():8329306. PubMed ID: 31080830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.
    Baker JA; Pereira G
    Clin Rehabil; 2013 Dec; 27(12):1084-96. PubMed ID: 23864518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.
    Rosales RL; Chua-Yap AS
    J Neural Transm (Vienna); 2008; 115(4):617-23. PubMed ID: 18322637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.
    Wu T; Li JH; Song HX; Dong Y
    Top Stroke Rehabil; 2016 Jun; 23(3):217-23. PubMed ID: 27077980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
    Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.
    Fiore P; Santamato A; Ranieri M; Bellomo RG; Saggini R; Panza F; Megna G; Cristella G; Megna M
    Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):57S-62S. PubMed ID: 22652163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial.
    Hesse S; Reiter F; Konrad M; Jahnke MT
    Clin Rehabil; 1998 Oct; 12(5):381-8. PubMed ID: 9796928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach.
    Baker JA; Pereira G
    Clin Rehabil; 2016 Jun; 30(6):549-58. PubMed ID: 26150020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.